The ECOG E4201 study adds another piece of information to a growing body of evidence pointing strongly to the importance of local control and the role of radiotherapy in unresectable pancreatic cancer. Based on this evidence, we believe radiotherapy should be used routinely in this setting.boxed-text
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
Journal of Experimental & Clinical Cancer Research Open Access 13 February 2018
-
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
Cell Death & Disease Open Access 06 December 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loehrer, P. J. Sr et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J. Clin. Oncol. 29, 4105–4112 (2011).
Iacobuzio-Donahue, C. A. et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J. Clin. Oncol. 27, 1806–1813 (2009).
Chauffert, B. et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study. Ann. Oncol. 19, 1592–1599 (2008).
Ceha, H. M. et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 89, 2222–2229 (2000).
Shewach, D. S. & Lawrence, T. S. Antimetabolite radiosensitizers. J. Clin. Oncol. 25, 4043–4050 (2007).
Lawrence T. S., Chang, E. Y., Hahn, T. M., Hertel, L. W. & Shewach, D. S. Radiosensitization of pancreatic cancer cells by 2′, 2′-difluoro-2′-deoxycytidine. Int. J. Radiat. Oncol. Biol. Phys. 34, 867–872 (1996).
McGinn, C. J. et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J. Clin. Oncol. 19, 4202–4208 (2001).
Bockbrader, M. & Kim, E. Role of intensity-modulated radiation therapy in gastrointestinal cancer. Expert. Rev. Anticancer Ther. 9, 637–647 (2009).
Ben-Josef, E. et al. Phase I/II radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G.) for unresectable pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 81 (Suppl. 2), 127–128 (2011).
Murphy, J. D. et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 68, 801–808 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ben-Josef, E., Lawrence, T. The importance of local control in pancreatic cancer. Nat Rev Clin Oncol 9, 9–10 (2012). https://doi.org/10.1038/nrclinonc.2011.182
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2011.182
This article is cited by
-
microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
Journal of Experimental & Clinical Cancer Research (2018)
-
Comparison of four target volume definitions for pancreatic cancer
Strahlentherapie und Onkologie (2013)
-
Identification of Distinct Phenotypes of Locally Advanced Pancreatic Adenocarcinoma
Journal of Gastrointestinal Cancer (2013)
-
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
Cell Death & Disease (2012)